153 related articles for article (PubMed ID: 27488511)
1. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.
Poupeau C; Tanguay C; Plante C; Gagné S; Caron N; Bussières JF
J Oncol Pharm Pract; 2017 Jul; 23(5):323-332. PubMed ID: 27084515
[TBL] [Abstract][Full Text] [Related]
3. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
Sabatini L; Barbieri A; Lodi V; Violante FS
Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
Hon CY; Teschke K; Shen H; Demers PA; Venners S
Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912
[TBL] [Abstract][Full Text] [Related]
5. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
[TBL] [Abstract][Full Text] [Related]
6. Occupational exposure to cyclophosphamide.
Hirst M; Tse S; Mills DG; Levin L; White DF
Lancet; 1984 Jan; 1(8370):186-8. PubMed ID: 6141334
[TBL] [Abstract][Full Text] [Related]
7. Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.
Hedmer M; Höglund P; Cavallin-Ståhl E; Albin M; Jönsson BA
Int Arch Occup Environ Health; 2008 Jan; 81(3):285-93. PubMed ID: 17579883
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs.
Maeda S; Miyawaki K; Matsumoto S; Oishi M; Miwa Y; Kurokawa N
Yakugaku Zasshi; 2010 Jun; 130(6):903-10. PubMed ID: 20519870
[TBL] [Abstract][Full Text] [Related]
9. Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital.
Yoshida J; Koda S; Nishida S; Nakano H; Tei G; Kumagai S
Ann Occup Hyg; 2013 Mar; 57(2):251-60. PubMed ID: 23002276
[TBL] [Abstract][Full Text] [Related]
10. Biological monitoring of occupational exposure to 5-fluorouracil: urinary α-fluoro-β-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel.
Ndaw S; Denis F; Marsan P; d'Almeida A; Robert A
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2630-4. PubMed ID: 20207593
[TBL] [Abstract][Full Text] [Related]
11. A new, sensitive and versatile assay for quantitative determination of α-fluoro-β-alanine (AFBA) in human urine by using the reversed-phase ultrahigh performance-tandem mass spectrometry (rp-UHPLC-MS/MS) system.
Sottani C; Grignani E; Zaratin L; Santorelli D; Studioso E; Lonati D; Locatelli CA; Pastoris O; Negri S; Cottica D
Toxicol Lett; 2018 Dec; 298():164-170. PubMed ID: 30315949
[TBL] [Abstract][Full Text] [Related]
12. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.
Yuki M; Sekine S; Takase K; Ishida T; Sessink PJ
J Oncol Pharm Pract; 2013 Sep; 19(3):208-17. PubMed ID: 23060485
[TBL] [Abstract][Full Text] [Related]
13. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations.
Burgaz S; Karahalil B; Canhi Z; Terzioglu F; Ançel G; Anzion RB; Bos RP; Hüttner E
Hum Exp Toxicol; 2002 Mar; 21(3):129-35. PubMed ID: 12102538
[TBL] [Abstract][Full Text] [Related]
14. Biomonitoring of occupational exposure to 5-FU by assaying α-fluoro-β-alanine in urine with a highly sensitive UHPLC-MS/MS method.
Dhersin A; Atgé B; Martinez B; Titier K; Rousset M; Sidatt Cheikh El Moustaph M; Verdun-Esquer C; Molimard M; Villa A; Canal-Raffin M
Analyst; 2018 Aug; 143(17):4110-4117. PubMed ID: 30058665
[TBL] [Abstract][Full Text] [Related]
15. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study.
Palamini M; Dufour A; Therrien R; Delisle JF; Mercier G; Gagné S; Caron N; Bussières JF
J Oncol Pharm Pract; 2020 Dec; 26(8):1864-1870. PubMed ID: 32138611
[TBL] [Abstract][Full Text] [Related]
16. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
[TBL] [Abstract][Full Text] [Related]
17. Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
Ensslin AS; Stoll Y; Pethran A; Pfaller A; Römmelt H; Fruhmann G
Occup Environ Med; 1994 Apr; 51(4):229-33. PubMed ID: 8199663
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents.
Sottani C; Tranfo G; Faranda P; Minoia C
Rapid Commun Mass Spectrom; 2005; 19(19):2794-800. PubMed ID: 16144038
[TBL] [Abstract][Full Text] [Related]
19. Occupational exposure to cyclophosphamide in nurses at a single center.
Ramphal R; Bains T; Vaillancourt R; Osmond MH; Barrowman N
J Occup Environ Med; 2014 Mar; 56(3):304-12. PubMed ID: 24481248
[TBL] [Abstract][Full Text] [Related]
20. A pooled analysis to study trends in exposure to antineoplastic drugs among nurses.
Fransman W; Peelen S; Hilhorst S; Roeleveld N; Heederik D; Kromhout H
Ann Occup Hyg; 2007 Apr; 51(3):231-9. PubMed ID: 17337460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
